Results depend on dose exposure, adherence, protein intake, and activity
It might also increase the severity of some neurological symptoms like seizures, and may interact with some anticoagulants such as warfarin
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) conferred a greater risk reduction in all-cause mortality, despite inferior weight loss results when compared with bariatric surgery, researchers noted
While early GLP1 drugs focused primarily on diabetes, newer agents, such as tirzepatidebased therapies, have gained traction in treating obesity, raising efficacy expectations and increasing competitive dynamics
For histological subtype analyses, GWAS summary statistics were obtained from the OCAC, which included 40,941 controls and cases stratified by histotype: 13,037 HGSOC, 1012 LGSOC, 2810 ENOC, 1417 invasive MOC, and 1366 CCOC 4